Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial.

[1]  R. Schrier,et al.  The ABCD (Appropriate Blood Pressure Control in Diabetes) trial. Rationale and design of a trial of hypertension control (moderate or intensive) in type II diabetes. , 1993, The Online journal of current clinical trials.

[2]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[3]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[4]  J. Polak,et al.  Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. , 1993, Circulation.

[5]  R. DeFronzo,et al.  The natural history of diabetic nephropathy. , 1990, Seminars in nephrology.

[6]  D. Rodgerson,et al.  Evaluation of the Behring Nephelometer for detection of low level urinary albumin. , 1990, American journal of clinical pathology.

[7]  E. Bass,et al.  Epidemiological Correlates of Diabetic Neuropathy: Report From Pittsburgh Epidemiology of Diabetes Complications Study , 1989, Diabetes.

[8]  B. Brenner,et al.  Short and long term effects of antihypertensive therapy in the diabetic rat. , 1989, Kidney international.

[9]  E. Standl,et al.  Prevention and Treatment of Diabetic Late Complications , 1989 .

[10]  H. Parving,et al.  Protection of kidney function and decrease in albuminuria by captopril in insulin dependent diabetics with nephropathy. , 1988, BMJ.

[11]  L. Antiga,et al.  Captopril in patients with type II diabetes and renal insufficiency: systemic and renal hemodynamic alterations. , 1988, The American journal of medicine.

[12]  P. Bennett,et al.  Prevalence of Diabetes and Impaired Glucose Tolerance and Plasma Glucose Levels in U.S. Population Aged 20–74 Yr , 1987, Diabetes.

[13]  P Kligfield,et al.  Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings. , 1987, Circulation.

[14]  C. E. Mogensen Microalbuminuria as a predictor of clinical diabetic nephropathy. , 1987, Kidney international.

[15]  T. Aizawa,et al.  High Blood Pressure as Risk Factor in Diabetic Retinopathy Development in NIDDM Patients , 1987, Diabetes Care.

[16]  H. Janka,et al.  Systolic Blood Pressure as a Predictor for Cardiovascular Disease in Diabetes: A 5‐Year Longitudinal Study , 1985, Hypertension.

[17]  H. Keen,et al.  MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUS , 1982, The Lancet.

[18]  M. Meyer,et al.  Role of risk factors in complications of diabetes mellitus. , 1980, American journal of epidemiology.

[19]  E. Sonnenblick,et al.  Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. , 1980, American heart journal.

[20]  P. Bennett,et al.  Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians. , 1980, The New England journal of medicine.

[21]  R. C. Scott,et al.  A Critical Appraisal of the Electrocardiographic Criteria for the Diagnosis of Left Ventricular Hypertrophy , 1969, Circulation.

[22]  B. Balkau,et al.  Epidemiology of peripheral arterial disease. , 1994, Journal of cardiovascular pharmacology.

[23]  N. Stern,et al.  Diabetes and hypertension. , 1992, Journal of cardiovascular pharmacology.

[24]  R. Hamman,et al.  Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. , 1990, Journal of clinical epidemiology.

[25]  W. G. Walker,et al.  Elevated blood pressure and angiotensin II are associated with accelerated loss of renal function in diabetic nephropathy. , 1986, Transactions of the American Clinical and Climatological Association.

[26]  N. Shulman,et al.  Hypertension in blacks: Epidemiology, pathophysiology, and treatment , 1985 .

[27]  M. Sokolow,et al.  The ventricular complex in right ventricular hypertrophy as obtained by unipolar precordial and limb leads. , 1949, American heart journal.